CN1559467A - 一种治疗慢性肾炎的药物及其制备方法 - Google Patents
一种治疗慢性肾炎的药物及其制备方法 Download PDFInfo
- Publication number
- CN1559467A CN1559467A CNA2004100063539A CN200410006353A CN1559467A CN 1559467 A CN1559467 A CN 1559467A CN A2004100063539 A CNA2004100063539 A CN A2004100063539A CN 200410006353 A CN200410006353 A CN 200410006353A CN 1559467 A CN1559467 A CN 1559467A
- Authority
- CN
- China
- Prior art keywords
- medicine
- filtrate
- weight portion
- weight portions
- relative density
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 77
- 206010018367 Glomerulonephritis chronic Diseases 0.000 title claims abstract description 12
- 229940079593 drug Drugs 0.000 title claims description 17
- 238000000034 method Methods 0.000 title abstract description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 17
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 17
- 235000008434 ginseng Nutrition 0.000 claims abstract description 17
- 239000000706 filtrate Substances 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- 241000208340 Araliaceae Species 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 11
- 239000004615 ingredient Substances 0.000 claims description 11
- 241000222640 Polyporus Species 0.000 claims description 10
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 10
- 238000005303 weighing Methods 0.000 claims description 7
- 238000001556 precipitation Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- -1 drying Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 210000003734 kidney Anatomy 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 3
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 210000002700 urine Anatomy 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 10
- 201000008383 nephritis Diseases 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 8
- 102000007562 Serum Albumin Human genes 0.000 description 7
- 108010071390 Serum Albumin Proteins 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 238000012353 t test Methods 0.000 description 6
- 102000009027 Albumins Human genes 0.000 description 5
- 108010088751 Albumins Proteins 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000003907 kidney function Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000004379 membrane Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 206010003445 Ascites Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- 241001489978 Eupolyphaga Species 0.000 description 1
- 241001251068 Formica fusca Species 0.000 description 1
- 206010018364 Glomerulonephritis Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 231100000749 chronicity Toxicity 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 210000000585 glomerular basement membrane Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 208000009928 nephrosis Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000007560 sedimentation technique Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 剂量(g/Kg) | 尿蛋白 (mg/dl) | |||||
药前 | 给药6天 | 给药9天 | 给药12天 | 给药18天 | 给药21天 | ||
模型 | 400±164(14) | 380±153(13) | 290±21.1(10) | 295±15.8(10) | 275±35.4(10) | 272±26.4(9) | |
A药 | 17.4 | 375±149(14) | 315±103(11) | 275±26.4(10) | 257±73.2(7) | 242±73.6(6) | 203±78(6) |
A药 | 52.2 | 400±164(14) | 359±144(8) | 286±24.4(7) | 267±40.8(6) | 238±94.6(4) | 213±75(4) |
B药 | 14.1 | 375±149(14) | 300±0(12) | 275±26.1(12) | 264±32.3(11)* | 225±54(10)* | 230±35(10)* |
B药 | 42.3 | 400±164(14) | 300±0(13) | 273±26.1(11) | 265±33.7(10)* | 230±25.8(10)** | 190±56.8(10)** |
组别 | 剂量(g/Kg) | 尿素氮 (mmol/L) | ||
给药7天 | 给药14天 | 给药21天 | ||
模型 | 22.3±9.4(12) | 11.6±5.6(10) | 10.4±4.6(9) | |
A药 | 17.4 | 23.4±6.9(12) | 9.7±3.9(7) | 8.3±4.7(6) |
A药 | 52.2 | 22.5±10.3(9) | 7.5±1.5(5) | 6.9±0.9(4) |
B药 | 14.1 | 17.7±5.3(12) | 9.8±3.4(10) | 8.5±2.4(10) |
B药 | 42.3 | 26.6±7.4(12) | 11.7±5.2(10) | 10.3±4.0(10) |
组别 | 剂量(g/Kg) | 白蛋白 (g/L) | ||
给药7天 | 给药14天 | 给药21天 | ||
模型 | 23.0±1.5(12) | 26.3±2.1(10) | 29.0±2.6(9) | |
A药 | 17.4 | 24.1±3.6(12) | 30.2±2.1(7)** | 30.5±1.1(6) |
A药 | 52.2 | 23.2±2.4(9) | 23.8±3.4(5) | 26.0±1.7(4)** |
B药 | 14.1 | 24.4±2.6(12) | 26.8±3.6(10) | 27.4±2.5(10) |
B药 | 42.3 | 25.7±3.6(12)** | 28.3±2.4(10) | 30.1±1.7(10) |
组别 | 剂量(g/Kg) | 尿蛋白 (mg/dl) | |||
药前 | 给药7天 | 给药14天 | 给药21天 | ||
模型 | 340±128(15) | 340±128(15) | 304±113(14) | 249±78(14) | |
A药 | 8.7 | 354±131(13) | 323±99(13) | 245±44(10) | 220±35(10) |
A药 | 17.4 | 346±138(13) | 323±99(13) | 232±51(11) | 209±66(11) |
B药 | 7.0 | 354±131(13) | 296±14(13) | 221±58(12)** | 204±50(12) |
B药 | 14.1 | 345±138(13) | 296±14(13) | 225±54(12)** | 188±38(12)* |
组别 | 剂量(g/Kg) | 尿素氮 (mmol/L) | ||
给药7天 | 给药14天 | 给药21天 | ||
模型 | 21.1±15.5(15) | 10.1±4.3(14) | 8.2±1.7(14) | |
A药 | 8.7 | 23.4±10.6(13) | 12.2±4.6(10) | 9.5±2.4(10) |
A药 | 17.4 | 18.6±8.3(13) | 8.5±1.7(11) | 8.0±2.6(11) |
B药 | 7.0 | 20.9±11.2(13) | 11.1±5.7(12) | 8.0±2.1(11) |
B药 | 14.1 | 19.2±8.0(13) | 9.9±3.0(12) | 8.2±1.5(12) |
组别 | 剂量(g/Kg) | 白蛋白 (g/L) | ||
给药7天 | 给药14天 | 给药21天 | ||
模型 | 24.5±3.5(15) | 28.4±4.6(14) | 27.3±1.6(14) | |
A药 | 8.7 | 25.1±3.1(13) | 32.2±3.6(10)* | 30.5±2.9(10)** |
A药 | 17.4 | 26.2±3.2(13) | 26.8±3.5(11) | 28.6±3.7(4) |
B药 | 7.0 | 26.5±3.2(13) | 31.5±4.1(12) | 29.8±2.9(10)* |
B药 | 14.1 | 25.7±2.8(13) | 31.8±2.2(12)* | 29.2±2.4(10)* |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410006353 CN1269509C (zh) | 2004-02-27 | 2004-02-27 | 一种治疗慢性肾炎的药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410006353 CN1269509C (zh) | 2004-02-27 | 2004-02-27 | 一种治疗慢性肾炎的药物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1559467A true CN1559467A (zh) | 2005-01-05 |
CN1269509C CN1269509C (zh) | 2006-08-16 |
Family
ID=34439760
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200410006353 Expired - Lifetime CN1269509C (zh) | 2004-02-27 | 2004-02-27 | 一种治疗慢性肾炎的药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1269509C (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103623332A (zh) * | 2013-12-10 | 2014-03-12 | 刘晓伟 | 一种治疗肾周围炎的中药 |
-
2004
- 2004-02-27 CN CN 200410006353 patent/CN1269509C/zh not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103623332A (zh) * | 2013-12-10 | 2014-03-12 | 刘晓伟 | 一种治疗肾周围炎的中药 |
Also Published As
Publication number | Publication date |
---|---|
CN1269509C (zh) | 2006-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101837065B (zh) | 抗肝炎、抗肿瘤及提高机体免疫功能的药物及其制备方法 | |
CN1836720A (zh) | 一种治疗关节炎或痛风的中药组合物及其制备方法 | |
CN1839944A (zh) | 降脂颗粒组合物及其制备方法 | |
CN103705754A (zh) | 一种治疗系统性红斑狼疮的中药组合物 | |
CN1201782C (zh) | 一种治疗乳腺增生的药物组合物及其制备方法 | |
CN1269509C (zh) | 一种治疗慢性肾炎的药物及其制备方法 | |
CN1965951A (zh) | 驴胶补血胶囊及制备方法 | |
CN1899448A (zh) | 一种治疗弱视的中药复方制剂及其制备方法 | |
CN1052889C (zh) | 一种治疗肝炎的中成药 | |
CN1270750C (zh) | 一种治疗慢性肾炎的药物及其制备方法 | |
CN101543574B (zh) | 一种治疗肺间质纤维化的中药组合物 | |
CN1857605A (zh) | 治疗慢性酒精中毒性肝病的药物及其制备方法 | |
CN1298366C (zh) | 一种用于治疗原发性低血压病的药物组合物 | |
CN1294980C (zh) | 一种治疗肝病的药 | |
CN1233364C (zh) | 一种治疗消化性溃疡的中药及其制法 | |
CN1176690C (zh) | 一种治疗慢性肾炎的药物 | |
CN104645144A (zh) | 一种治疗肾炎的中药制剂及其制备方法 | |
CN111773330A (zh) | 一种治疗帕金森病的中药组合物及其制备方法 | |
CN1274338C (zh) | 治疗再生障碍性贫血的中药及其制备工艺 | |
CN113876919B (zh) | 一种活血化瘀的中药组合物和药物制剂及其应用 | |
CN1036503C (zh) | 治疗系统性红斑狼疮的药物及其生产方法 | |
CN1128634C (zh) | 一种治疗乙肝的纯中药制剂 | |
CN1823945A (zh) | 用于治疗脂肪肝的中药制剂及其制备方法 | |
CN1660282A (zh) | 一种治疗乙型肝炎的药物组合物及其制备方法 | |
CN1042495C (zh) | 一种益气消癌升高白细胞的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: ZHUHAI ANSHENG FENGHUANG PHARMACEUTICAL Co.,Ltd. Assignor: Li Guocheng Contract fulfillment period: 2007.1.1 to 2012.1.1 Contract record no.: 2009440001629 Denomination of invention: Medicine for treating chronic nephritis and its preparing process Granted publication date: 20060816 License type: Exclusive license Record date: 20091021 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2007.1.1 TO 2012.1.1; CHANGE OF CONTRACT Name of requester: ZHUHAI ANSHENG FENGHUANG PHARMACY CO., LTD. Effective date: 20091021 |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20060816 |